Lacosamide Patent Expiration
Lacosamide is Used for treating partial-onset seizures in patients with epilepsy aged 17 years and older, either as adjunctive therapy or when oral treatment is temporarily not feasible. It was first introduced by Ucb Inc
Lacosamide Patents
Given below is the list of patents protecting Lacosamide, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Motpoly Xr | US11337943 | Lacosamide pharmaceutical composition and dosage form thereof | Jun 05, 2040 | Aucta |
Vimpat | US5654301 | Amino acid derivative anticonvulsant |
Aug 05, 2014
(Expired) | Ucb Inc |
Vimpat | USRE38551 | Anticonvulsant enantiomeric amino acid derivatives |
Mar 17, 2022
(Expired) | Ucb Inc |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳
Lacosamide Generics
Several generic applications have been filed for Lacosamide. The first generic version for Lacosamide was by Mylan Pharmaceuticals Inc and was approved on Apr 28, 2016. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on May 24, 2024.
Given below is the list of companies who have filed for Lacosamide generic.
1. ASPIRO
Aspiro Pharma Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Aspiro.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/20ML (10MG/ML) | solution | Prescription | INTRAVENOUS | AP | Sep 14, 2022 |
2. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG/ML | solution | Prescription | ORAL | AA | May 31, 2022 |
3. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
200MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
50MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
100MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
10MG/ML | solution | Discontinued | ORAL | N/A | Mar 27, 2024 |
4. MSN
Msn Laboratories Private Ltd has filed for 2 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Msn.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/20ML (10MG/ML) | solution | Prescription | INTRAVENOUS | AP | Feb 9, 2023 |
10MG/ML | solution | Prescription | ORAL | AA | Dec 22, 2023 |
5. APOTEX
Apotex Inc has filed for 6 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Apotex.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG | tablet | Discontinued | ORAL | N/A | Sep 23, 2022 |
100MG | tablet | Discontinued | ORAL | N/A | Sep 23, 2022 |
150MG | tablet | Discontinued | ORAL | N/A | Sep 23, 2022 |
200MG | tablet | Discontinued | ORAL | N/A | Sep 23, 2022 |
10MG/ML | solution | Prescription | ORAL | AA | Sep 26, 2022 |
200MG/20ML (10MG/ML) | solution | Prescription | INTRAVENOUS | AP | Nov 13, 2023 |
6. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Alembic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
100MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
150MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
200MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
7. MSN LABS PVT LTD
Msn Laboratories Private Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Msn Labs Pvt Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
100MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
150MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
200MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
8. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/20ML (10MG/ML) | solution | Prescription | INTRAVENOUS | AP | Sep 19, 2022 |
9. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/20ML (10MG/ML) | solution | Prescription | INTRAVENOUS | AP | Apr 5, 2024 |
10. HAINAN POLY
Hainan Poly Pharm Co Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Hainan Poly.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/20ML (10MG/ML) | solution | Prescription | INTRAVENOUS | AP | Feb 13, 2024 |
11. INDOCO
Indoco Remedies Ltd has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Indoco.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
150MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
100MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
50MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
200MG/20ML (10MG/ML) | solution | Prescription | INTRAVENOUS | AP | Apr 7, 2022 |
12. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/20ML (10MG/ML) | solution | Prescription | INTRAVENOUS | AP | Jun 29, 2022 |
200MG | tablet | Discontinued | ORAL | N/A | Dec 15, 2023 |
50MG | tablet | Discontinued | ORAL | N/A | Dec 15, 2023 |
150MG | tablet | Discontinued | ORAL | N/A | Dec 15, 2023 |
100MG | tablet | Discontinued | ORAL | N/A | Dec 15, 2023 |
13. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG | tablet | Discontinued | ORAL | N/A | Jul 12, 2022 |
200MG | tablet | Discontinued | ORAL | N/A | Jul 12, 2022 |
150MG | tablet | Discontinued | ORAL | N/A | Jul 12, 2022 |
100MG | tablet | Discontinued | ORAL | N/A | Jul 12, 2022 |
14. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG/ML | solution | Prescription | ORAL | AA | May 15, 2024 |
15. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
200MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
50MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
100MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
16. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
100MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
200MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
50MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
17. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/20ML (10MG/ML) | solution | Prescription | INTRAVENOUS | AP | May 3, 2022 |
18. LEADING PHARMA
Leading Pharma Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Leading Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG/ML | solution | Prescription | ORAL | AA | Feb 6, 2023 |
19. NOVITIUM PHARMA
Novitium Pharma Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Novitium Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG/ML | solution | Prescription | ORAL | AA | Aug 26, 2022 |
20. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
50MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
100MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
150MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
21. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet | Prescription | ORAL | AB | May 24, 2024 |
150MG | tablet | Prescription | ORAL | AB | May 24, 2024 |
100MG | tablet | Prescription | ORAL | AB | May 24, 2024 |
50MG | tablet | Prescription | ORAL | AB | May 24, 2024 |
22. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG | tablet | Prescription | ORAL | AB | Apr 28, 2016 |
200MG | tablet | Prescription | ORAL | AB | Apr 28, 2016 |
100MG | tablet | Prescription | ORAL | AB | Apr 28, 2016 |
50MG | tablet | Prescription | ORAL | AB | Apr 28, 2016 |
23. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Dr Reddys.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/20ML (10MG/ML) | solution | Prescription | INTRAVENOUS | AP | Mar 25, 2024 |
24. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
50MG | tablet | Prescription | ORAL | AB | Jan 5, 2023 |
100MG | tablet | Prescription | ORAL | AB | Jan 5, 2023 |
150MG | tablet | Prescription | ORAL | AB | Jan 5, 2023 |
200MG | tablet | Prescription | ORAL | AB | Jan 5, 2023 |
10MG/ML | solution | Prescription | ORAL | AA | Jan 24, 2024 |
25. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Sun Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
200MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
50MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
100MG | tablet | Prescription | ORAL | AB | Mar 17, 2022 |
26. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG | tablet | Prescription | ORAL | AB | Mar 31, 2022 |
100MG | tablet | Prescription | ORAL | AB | Mar 31, 2022 |
50MG | tablet | Prescription | ORAL | AB | Mar 31, 2022 |
200MG | tablet | Prescription | ORAL | AB | Mar 31, 2022 |
10MG/ML | solution | Prescription | ORAL | AA | May 19, 2022 |
27. MEDLEY PHARMS
Medley Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Medley Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
150MG | tablet | Prescription | ORAL | AB | Apr 2, 2024 |
100MG | tablet | Prescription | ORAL | AB | Apr 2, 2024 |
50MG | tablet | Prescription | ORAL | AB | Apr 2, 2024 |
200MG | tablet | Prescription | ORAL | AB | Apr 2, 2024 |
28. ACTAVIS LABS FL INC
Actavis Laboratories Fl Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG | tablet | Discontinued | ORAL | N/A | Jan 5, 2023 |
50MG | tablet | Discontinued | ORAL | N/A | Jan 5, 2023 |
150MG | tablet | Discontinued | ORAL | N/A | Jan 5, 2023 |
200MG | tablet | Discontinued | ORAL | N/A | Jan 5, 2023 |